Michael Makris: How Haemophilia Care Is Delivered in China
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at University of Sheffield, reposted from RPTH Journal on LinkedIn:
”If you would like to know how haemophilia care is delivered in China then have a look at this paper.”
Quoting RPTH Journal‘s post about a recent article by Yun Wang et al, adding:
”Inherited bleeding disorders in China: a rapidly evolving therapeutic and healthcare landscape
With over 1.4 billion people, China faces a growing demand for the diagnosis and treatment of inherited bleeding disorders (IBDs), particularly haemophilia.
A new review in RPTH Journal takes stock of the remarkable progress made in recent years and the road ahead.
Key highlights:
- China is rapidly expanding its domestic manufacturing capacity for IBD therapeutics, from basic replacement therapies to advanced treatments including gene therapy
- A tiered healthcare system for haemophilia is being developed to optimise resource allocation and standardise care across both rural and urban areas
- A diverse pipeline of investigational domestic novel drugs is under active development
- The goal: more efficient, cost-effective, and accessible care for patients nationwide
This review offers a comprehensive overview of where China stands today, and where it is headed, in the management of inherited bleeding disorders.
The combination of domestic drug innovation and an evolving healthcare delivery system could significantly improve outcomes and quality of life for patients across the country.”
Title: The therapeutic landscape of inherited bleeding disorders in China
Authors: Yun Wang, Feng Xue, Man-Chiu Poon, Renchi Yang
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 3, 2026, 15:36Alexandros Makis: 20-year Cohort of 112 Children with Autoimmune Neutropenia
-
Jun 3, 2026, 15:30Aravind Palraj: Young Stroke? – Think Beyond APS
-
Jun 3, 2026, 15:09Alissa Rumin: Starting a New Chapter in Hemophilia and Thrombosis Research
-
Jun 3, 2026, 15:02Yauheniya Baranchykava: Changing Lives Through Innovation in Hemophilia Care
-
Jun 3, 2026, 15:01Danielle Leitner Baxter: 15 Years of Supporting the Bleeding Disorders Community
-
Jun 3, 2026, 14:44Brandy Seyller: Why Understanding the Coagulation Cascade Matters in Bleeding Cases
-
Jun 3, 2026, 14:33Anna Tobiasch: Should Fibrinogen and FXIII Be Restored Together After Severe Haemodilution?
-
Jun 3, 2026, 14:32Ifeanyichukwu Ifechidere: Coagulation Disorder or DOAC Interference?
-
Jun 3, 2026, 14:30Daniela Pachito: Honored to Present Four Research Posters at ISPOR 2026